Singapore HSA Updates Health Supplement & Traditional Medicines Labelling Guideline

HSA updates GUIDELINES FOR LABELLING STANDARDS OF HEALTH SUPPLEMENTS AND TRADITIONAL MEDICINES including clarification on labelling requirements on the name …

read more...

Singapore HSA Accepts MDSAP certification for Medical Device’s QMS Certification

Singapore HSA included Medical Device Singapore Audit Program (MDSAP) certification as one of the acceptable lists of Medical Device’s QMS …

read more...

Singapore HSA Updates Advertisement Guidance for Therapeutic Products

Singapore’s Health Sciences Authority (HSA) updated EXPLANATORY GUIDANCE TO THE HEALTH PRODUCTS (ADVERTISEMENT OF SPECIFIED HEALTH PRODUCTS) REGULATIONS for Therapeutic …

read more...

Singapore HSA Updates Guidance on the Risk Classification of IVD Medical Devices (GN-14)

Singapore’s Health Sciences Authority (HSA) has finalised the updated GN-14 Guidance on the Risk Classification of In Vitro Diagnostic Medical …

read more...

Singapore HSA Announces Phase 2 of Voluntary Notification of Health Supplements and Traditional Medicines

Singapore Health Sciences Authority (HSA) had implemented the first phase voluntary notification initiative for Health Supplements and Traditional Medicines on …

read more...

Singapore HSA Updates Therapeutic Product Registration Guidelines

As part of Singapore HSA’s ongoing initiatives to improve regulatory efficiency and enhance clarity in HSA’s regulatory requirements and processes, …

read more...

Singapore HSA Revises Guideline on Consignment Importation of Therapeutic Product

Singapore HSA revised Guideline on Import a Therapeutic Product on Consignment Basis. The revised guideline provides further clarity to the …

read more...

Singapore HSA Updates Guidance on Unregistered Therapeutic Product Import and Supply

In March 2023, HSA updated Guidance on Import and Supply of An Unregistered Therapeutic Product For Patients’ Use. See Pharma …

read more...

Singapore HSA Updates Unregistered Therapeutic Product Import and Supply Guidance and Forms

Singapore HSA Updates Guidance TPB-GN-004-005 regarding the Import and Supply of an Unregistered Therapeutic Product For Patients’ Use. HSA includes …

read more...

More News